Antipodes Partners’s Frontline FRO Stock Holding History

Antipodes Partners’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,012	Closed	-$33K	–	71
2023 Q1	$33K	Sell	2,012 -3,692,024	-100%	-$58.1M	﹤0.01%	57
2022 Q4	$44.8M	Sell	3,694,036 -688,129	-16%	-$8.84M	1.61%	26
2022 Q3	$47.9M	Buy	+4,382,165	New	+$48M	1.92%	23

Other funds holding FRO

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Antipodes Partners's FRO Position: Q2 2023 in Review

Antipodes Partners sold out of Frontline (FRO) in Q2 2023, closing a stake of 2,012 shares — an estimated $33K sold.

Antipodes Partners first reported a position in FRO in Q3 2022 and held it in 3 quarters. The position peaked at $47.9M in Q3 2022. 163 funds tracked by Wall St. Rank hold FRO as of Q2 2023.

Antipodes Partners reported no remaining Frontline position as of Q2 2023 after selling out during the quarter.
Antipodes Partners sold 2,012 Frontline shares in Q2 2023, an estimated $33K.
Antipodes Partners first reported a position in Frontline in Q3 2022 and held it in 3 quarters.
Antipodes Partners's Frontline position peaked at $47.9M in Q3 2022.
163 funds tracked by Wall St. Rank held Frontline as of Q2 2023.

Based on Antipodes Partners's 13F filing for Q2 2023, filed 25 Jul 2023.